We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pocket Test Measures Fifty Diagnostic Parameters

By LabMedica International staff writers
Posted on 03 Jan 2013
A small device could allow health care providers to test for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection simultaneously. More...


The novel device is about the size of a business card and is called the multiplexed volumetric bar-chart chip or V-chip and uses as little as one µL of blood for all the point-of-care- tests.

Scientists at the Methodist Hospital Research Institute (Houston, TX, USA) developed the V-chip, which is composed of two thin pieces of glass that are about 7.6 cm by 5.1 cm. In between are four wells: for hydrogen peroxide; for up to 50 different antibodies to specific proteins, DNA or RNA fragments, or lipids of interest, and the enzyme catalase; for serum or other sample; and for a suitable dye. Initially, the wells are kept separate from each other. A shift in the glass plates brings the wells into contact, creating a contiguous, zigzagged space from one end of the V-chip to the other.

When the substance of interest, such as insulin, binds to antibodies bound to the glass slide, catalase is made active and splits nearby hydrogen peroxide into water and oxygen gas. This approach resembles enzyme-linked immunosorbent assay (ELISA) methods. The oxygen pushes the dye up the column. The more insulin present, the more oxygen is created, and the farther dye is pushed up the slide. Tests show that distance is more or less proportional to the amount of substrate present. The end result is a visual bar chart. The device is easy to read and accurate.

Lidong Qin, PhD, the project's principal investigator, said, "The V-Chip could make it possible to bring tests to the bedside, remote areas, and other types of point-of-care needs. V-Chip is accurate, cheap, and portable. It requires only a drop of a sample, not a vial of blood, and can do 50 different tests in one go. The sensitivity of the V-chip can be improved if narrower and longer bar channels are used. Our next steps are to make the device more user friendly and be so simple to use, it barely needs instructions." The study was published on December 18, 2012, in the journal Nature Communications.

The Methodist Hospital Research Institute


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.